PMID- 13129650 OWN - NLM STAT- MEDLINE DCOM- 20031216 LR - 20181130 IS - 0928-8244 (Print) IS - 0928-8244 (Linking) VI - 38 IP - 2 DP - 2003 Sep 22 TI - Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae. PG - 159-64 AB - Atherosclerosis has been linked to Chlamydia pneumoniae infection. In atherosclerotic arteries chlamydiae infect macrophages, endothelial cells, and smooth muscle cells (SMC). It has been suggested that the proteolysis of the extracellular matrix by matrix metalloproteinases (MMPs) is involved in the destabilisation and rupture of atherosclerotic plaques. In this study we investigated the expression of several MMPs and tissue inhibitors of MMP (TIMPs) in C. pneumoniae-infected SMC using reverse transcription-polymerase chain reaction analysis. Chlamydial infection of SMC up-regulated the mRNA levels of MMP-1 (interstitial collagenase) and MMP-3 (stromelysin) but did not affect the expression of MMP-2 and -9 (gelatinases). Additionally, the levels of TIMP-1 and -2 mRNA remained unchanged upon infection. Cells infected with C. pneumoniae secreted increased quantities of MMP-1 and -3 proteins as demonstrated by enzyme-linked immunosorbent assays. The ability of C. pneumoniae to stimulate the production of MMP-1 and -3 by SMC may be important for its pathogenic role in the progression of atherosclerotic disease. FAU - Rodel, Jurgen AU - Rodel J AD - Institute of Medical Microbiology, Friedrich Schiller University of Jena, Semmelweisstr. 4, D-07740 Jena, Germany. juergen.roedel@med.uni-jena.de FAU - Prochnau, Dirk AU - Prochnau D FAU - Prager, Katrin AU - Prager K FAU - Pentcheva, Evdokia AU - Pentcheva E FAU - Hartmann, Matthias AU - Hartmann M FAU - Straube, Eberhard AU - Straube E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - FEMS Immunol Med Microbiol JT - FEMS immunology and medical microbiology JID - 9315554 RN - 0 (RNA, Messenger) RN - 0 (Tissue Inhibitor of Metalloproteinases) RN - EC 3.4.- (Metalloproteases) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.7 (Matrix Metalloproteinase 1) SB - IM MH - Arteriosclerosis/microbiology/physiopathology MH - Cells, Cultured MH - Chlamydophila pneumoniae/*pathogenicity MH - Humans MH - Matrix Metalloproteinase 1/*biosynthesis/genetics MH - Matrix Metalloproteinase 3/*biosynthesis/genetics MH - Metalloproteases/metabolism MH - Muscle, Smooth, Vascular/cytology/*enzymology/microbiology MH - RNA, Messenger/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Tissue Inhibitor of Metalloproteinases/metabolism MH - *Up-Regulation EDAT- 2003/09/18 05:00 MHDA- 2003/12/17 05:00 CRDT- 2003/09/18 05:00 PHST- 2003/09/18 05:00 [pubmed] PHST- 2003/12/17 05:00 [medline] PHST- 2003/09/18 05:00 [entrez] AID - S0928824403001263 [pii] AID - 10.1016/S0928-8244(03)00126-3 [doi] PST - ppublish SO - FEMS Immunol Med Microbiol. 2003 Sep 22;38(2):159-64. doi: 10.1016/S0928-8244(03)00126-3.